
Genelux Corporation: updates and filings
Price
$2.17
November 20, 2026Market cap $104M
What Ploutos Investor adds for Genelux
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
An estimate from when it has reported before, which has been regular. The company announces the date itself.
March 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jun 22, 2026Shareholder voteForm8-K
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 29, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 29, 2026Additional annual meeting materialFormDEFA14A
- Apr 29, 2026Annual meeting proxy statementFormDEF 14A
- Mar 19, 2026Shares registered for employeesFormS-8
- Mar 19, 2026Material agreement enteredForm8-K
- Mar 19, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 17, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 2, 2026Regulation FD disclosureForm8-K
- Jan 8, 2026Other material eventsForm8-K
- Jan 5, 2026Regulation FD disclosure, other material eventsForm8-K
- Jan 2, 2026Officer or director changeForm8-K
- Nov 14, 2025Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 5, 2025Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Sep 3, 2025Officer or director change, shareholder voteForm8-K
- Aug 7, 2025Shares registered for employeesFormS-8
- Aug 7, 2025Quarterly reportfor the period to Jun 30, 2025Form10-Q
- Jul 25, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 11, 2025Annual report to shareholdersfor the period to Dec 31, 2024FormARS
- Jul 11, 2025Additional annual meeting materialFormDEFA14A
- Jul 11, 2025Annual meeting proxy statementFormDEF 14A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jun 22, 2026 | 8-K | Shareholder vote | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 29, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 29, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 29, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 19, 2026 | S-8 | Shares registered for employees | Document |
| Mar 19, 2026 | 8-K | Material agreement entered | Document |
| Mar 19, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 17, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 2, 2026 | 8-K | Regulation FD disclosure | Document |
| Jan 8, 2026 | 8-K | Other material events | Document |
| Jan 5, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jan 2, 2026 | 8-K | Officer or director change | Document |
| Nov 14, 2025 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 5, 2025 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Sep 3, 2025 | 8-K | Officer or director change, shareholder vote | Document |
| Aug 7, 2025 | S-8 | Shares registered for employees | Document |
| Aug 7, 2025 | 10-Q | Quarterly reportfor the period to Jun 30, 2025 | Document |
| Jul 25, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 11, 2025 | ARS | Annual report to shareholdersfor the period to Dec 31, 2024 | Document |
| Jul 11, 2025 | DEFA14A | Additional annual meeting material | Document |
| Jul 11, 2025 | DEF 14A | Annual meeting proxy statement | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 5, 2003.
The full analysis
What do Genelux's filings show?
The filings are where every one of Genelux's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.